Showing 10 posts by Alex S. Fisher.
Depending on the state in which a nurse practitioner or physician assistant practices, he or she can likely prescribe controlled and non-controlled substances to patients, within the parameters of the applicable state’s regulatory scheme. Nurse practitioners and physician assistants, referred to here as “midlevel providers,” continue to provide excellent care to their patients and move in greater numbers into the role of primary care providers for Americans. Nurse practitioners currently account for one in four providers in U.S. rural practices, a significant 43.2 percent increase over the past 10 years according to research just published in Health Affairs. Understanding the qualifications and responsibilities of midlevel providers in the context of prescribing is, therefore, essential. Read More ›
This is the third article in a three-part series designed to inform physicians and other health care providers about proactive steps that can be taken to avoid licensure discipline by the Department of Health. Read More ›
This is the second article in a three-part series designed to inform physicians and other health care providers about proactive steps that can be taken to avoid licensure discipline by their respective state Department of Health. Read More ›
This is the first article in a three-part series designed to inform physicians and other health care providers about proactive steps that can be taken to avoid licensure discipline by their respective state Department of Health. Read More ›
Health Care Models of the Future (Hint: They Include Nurse Practitioners!) and, 5 Tips for Hiring Nurse Practitioners
The individual mandate (i.e., that every American must have health insurance coverage or pay a penalty tax) has long been deemed the crux of Obamacare, or the glue that holds it all together. Read More ›
As we all know, health care providers such as physicians, nurse practitioners, and registered nurses are licensed with their State Board of Medical Examiners or Board of Nursing to legally practice medicine or nursing in the state of their licensure. State Departments of Health often receive complaints—and whether these complaints are valid or not—the State Department of Health may be legally obligated to investigate the complaint, if warranted. However, most providers—and their employers—tend to panic when notified that a provider is under investigation. So, what does it mean, exactly, for a provider to be under investigation, and what should a provider and their employer do about it? Read More ›
The Office of the Inspector General (OIG) of the U.S. Department of Health & Human Services maintains a list of healthcare providers who are excluded from participating in Medicare, Medicaid and all other federal health care programs. Read More ›
In many states, an investigation into a healthcare provider’s license by the Department of Health may begin with a phone call, letter, or in-person meeting between a healthcare provider and a Department of Health investigator. While all individuals have a right to have an attorney present at an interview with a Department of Health investigator, most individuals may not realize they have this right until after the interview has passed. Which may leave you asking: what now? Read More ›
What You Should Know Before You Agree to Licensure Discipline: Is It Reportable to the National Practitioner Data Bank?
The National Practitioner Data Bank, or NPDB, is a repository of information created by the federal government to provide a comprehensive review of the professional credentials of health care practitioners, including, but not limited to, any discipline a health care practitioner receives from a state medical board. Read More ›
Ask the Blogger
Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.
Brian F. Higgins is an associate in FBT's regulated business group with a focus on health care, and he has a history as corporate counsel to Medpace, Inc., a pharmaceutical clinical research organization.